Insights

Strategic Acquisition OpGen recently expanded through acquiring iCapX in a 12.3M share deal, signaling growth strategy and potential cross-sell opportunities for molecular diagnostics and AMR-focused panels.

AMR Focus The company concentrates on antimicrobial resistance diagnostics and antibiotic stewardship, suggesting a ready-made entry point for sales of multiplex molecular panels, aiding hospitals and labs in optimizing therapy choices.

Public Health Readiness NGS-based services launched to support public health indicate capacity for collaboration with health departments and larger healthcare networks seeking scalable genomic surveillance and outbreak response solutions.

Nascent Commercial Scale With a small employee base and revenue in the low single-digit millions, OpGen presents a high upside for channel partnerships, OEM arrangements, or strategic partnerships to accelerate market reach.

Leadership and Financing Recent leadership changes and new equity investments (including a CEO appointment and convertible instruments) point to evolving governance and liquidity events that could align with co-development or funded pilot opportunities.

Similar companies to OpGen, Inc.

OpGen, Inc. Tech Stack

OpGen, Inc. uses 8 technology products and services including MATLAB, iCIMS, SAS, and more. Explore OpGen, Inc.'s tech stack below.

Media & News

OpGen, Inc.'s Email Address Formats

OpGen, Inc. uses at least 3 email formats:
OpGen, Inc. Email FormatsExamplePercentage
FLast@opgen.comJDoe@opgen.com
96%
First.Last@opgen.comJohn.Doe@opgen.com
3%
First@opgen.comJohn@opgen.com
1%

Frequently Asked Questions

What is OpGen, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact OpGen, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OpGen, Inc.'s stock symbol?

Minus sign iconPlus sign icon
OpGen, Inc. is a publicly traded company; the company's stock symbol is OPGN.

What is OpGen, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
OpGen, Inc.'s official website is opgen.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does OpGen, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, OpGen, Inc.'s annual revenue is estimated to be $1M - $10M.

What is OpGen, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
OpGen, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OpGen, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, OpGen, Inc. has approximately 43 employees across 3 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: D. W., Chief Commercial Officer: R. M. L. and Chairman: B. R. Explore OpGen, Inc.'s employee directory with LeadIQ.

What industry does OpGen, Inc. belong to?

Minus sign iconPlus sign icon
OpGen, Inc. operates in the Biotechnology Research industry.

What technology does OpGen, Inc. use?

Minus sign iconPlus sign icon
OpGen, Inc.'s tech stack includes MATLAB, iCIMS, SAS, Amazon Web Services, WordPress, Shopify, Microsoft 365 and Google Cloud.

What is OpGen, Inc.'s email format?

Minus sign iconPlus sign icon
OpGen, Inc.'s email format typically follows the pattern of FLast@opgen.com. Find more OpGen, Inc. email formats with LeadIQ.

When was OpGen, Inc. founded?

Minus sign iconPlus sign icon
OpGen, Inc. was founded in 2002.
OpGen, Inc. logo

OpGen, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

OpGen, Inc. is a small biotechnology company based in Rockville, Maryland, that applies molecular microbiology to develop diagnostic tools for infectious diseases. Its work aims to guide antibiotic therapy decisions and support antibiotic stewardship to improve patient outcomes amid drug-resistant infections. The company develops multiplex diagnostic panels designed to identify multiple pathogens and resistance features, addressing antimicrobial resistance and reducing the spread of multidrug-resistant organisms.

Described as a precision medicine firm, OpGen focuses on molecular diagnostics to assist clinicians and public health entities in managing infectious diseases. In 2024, OpGen appointed David Lazar as chief executive officer, marking a leadership change noted in industry coverage.

Section iconCompany Overview

Phone number
Website
opgen.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
OPGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    OpGen, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.